|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Machlowska J, Baj J, Sitarz M, Maciejewski
R and Sitarz R: Gastric cancer: Epidemiology, risk factors,
classification, genomic characteristics and treatment strategies.
Int J Mol Sci. 21:40122020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie
Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA,
et al: Sarcopenia: Revised European consensus on definition and
diagnosis. Age Ageing. 48:6012019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng ZF, Lu J, Zheng CH, Li P, Xie JW,
Wang JB, Lin JX, Chen QY, Lin M and Huang CM: A novel prognostic
scoring system based on preoperative sarcopenia predicts the
long-term outcome for patients after R0 resection for gastric
cancer: Experiences of a high-volume center. Ann Surg Oncol.
24:1795–1803. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang M, Shen Y, Tan L and Li W: Prognostic
value of sarcopenia in lung cancer: A systematic review and
meta-analysis. Chest. 156:101–111. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Masanés F, Rojano I, Luque X, Salvà A,
Serra-Rexach JA, Artaza I, Formiga F, Cuesta F, López Soto A, Ruiz
D and Cruz-Jentoft AJ: Cut-off points for muscle mass-not grip
strength or gait speed-determine variations in sarcopenia
prevalence. J Nutr Health Aging. 21:825–829. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi AP, Fantin F, Micciolo R, Bertocchi
M, Bertassello P, Zanandrea V, Zivelonghi A, Bissoli L and Zamboni
M: Identifying sarcopenia in acute care setting patients. J Am Med
Dir Assoc. 15:303.e7–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Derstine BA, Holcombe SA, Ross BE, Wang
NC, Su GL and Wang SC: Skeletal muscle cutoff values for sarcopenia
diagnosis using T10 to L5 measurements in a healthy US population.
Sci Rep. 8:113692018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rollins KE, Gopinath A, Awwad A, Macdonald
IA and Lobo DN: Computed tomography-based psoas skeletal muscle
area and radiodensity are poor sentinels for whole L3 skeletal
muscle values. Clin Nutr. 39:2227–2232. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shachar SS, Williams GR, Muss HB and
Nishijima TF: Prognostic value of sarcopenia in adults with solid
tumours: A meta-analysis and systematic review. Eur J Cancer.
57:58–67. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McGovern J, Dolan RD, Horgan PG, Laird BJ
and McMillan DC: Computed tomography-defined low skeletal muscle
index and density in cancer patients: Observations from a
systematic review. J Cachexia Sarcopenia Muscle. 12:1408–1417.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martin L, Birdsell L, Macdonald N, Reiman
T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB and
Baracos VE: Cancer cachexia in the age of obesity: Skeletal muscle
depletion is a powerful prognostic factor, independent of body mass
index. J Clin Oncol. 31:1539–1547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Caan BJ, Meyerhardt JA, Kroenke CH,
Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL,
Quesenberry CP, Kwan ML and Prado CM: Explaining the obesity
paradox: The association between body composition and colorectal
cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev.
26:1008–1015. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Irving BA, Weltman JY, Brock DW, Davis CK,
Gaesser GA and Weltman A: NIH ImageJ and Slice-O-Matic computed
tomography imaging software to quantify soft tissue. Obesity
(Silver Spring). 15:370–376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dennis RA, Long DE, Landes RD, Padala KP,
Padala PR, Garner KK, Wise JN, Peterson CA and Sullivan DH:
Tutorial for using SliceOmatic to calculate thigh area and
composition from computed tomography images from older adults. PLoS
One. 13:e02045292018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JK, Park YS, Lee K, Youn SI, Won Y,
Min SH, Ahn SH, Park DJ and Kim HH: Prognostic significance of
surgery-induced sarcopenia in the survival of gastric cancer
patients: A sex-specific analysis. J Cachexia Sarcopenia Muscle.
12:1897–1907. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heymsfield SB, Gallagher D, Visser M,
Nuñez C and Wang ZM: Measurement of skeletal muscle: Laboratory and
epidemiological methods. J Gerontol A Biol Sci Med Sci. 50:Spec No.
23–29. 1995.PubMed/NCBI
|
|
20
|
Heymsfield SB, Adamek M, Gonzalez MC, Jia
G and Thomas DM: Assessing skeletal muscle mass: Historical
overview and state of the art. J Cachexia Sarcopenia Muscle.
5:9–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Williams GR, Deal AM, Muss HB, Weinberg
MS, Sanoff HK, Nyrop KA, Pergolotti M and Shachar SS: Skeletal
muscle measures and physical function in older adults with cancer:
Sarcopenia or myopenia? Oncotarget. 8:33658–33665. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng HY, Hou L, Zha P, Huang KL and Peng
L: Sarcopenia is an independent unfavorable prognostic factor of
non-small cell lung cancer after surgical resection: A
comprehensive systematic review and meta-analysis. Eur J Surg
Oncol. 45:728–735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin SB, Tian ZB, Ding XL, Guo YJ, Mao T,
Yu YN, Wang KX and Jing X: The impact of preoperative sarcopenia on
survival prognosis in patients receiving neoadjuvant therapy for
esophageal cancer: A systematic review and meta-analysis. Front
Oncol. 11:6195922021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakurai K, Kubo N, Tamura T, Toyokawa T,
Amano R, Tanaka H, Muguruma K, Yashiro M, Maeda K, Hirakawa K and
Ohira M: Adverse effects of low preoperative skeletal muscle mass
in patients undergoing gastrectomy for gastric cancer. Ann Surg
Oncol. 24:2712–2719. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng ZF, Lu J, Xie JW, Wang JB, Lin JX,
Chen QY, Cao LL, Lin M, Tu RH, Zheng CH, et al: Preoperative
skeletal muscle index vs the controlling nutritional status score:
Which is a better objective predictor of long-term survival for
gastric cancer patients after radical gastrectomy? Cancer Med.
7:3537–3547. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin J, Zhang W, Chen W, Huang Y, Wu R,
Chen X, Shen X and Zhu G: Muscle mass, density, and strength are
necessary to diagnose sarcopenia in patients with gastric cancer. J
Surg Res. 241:141–148. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong QT, Cai HY, Zhang Z, Zou HB, Dong WX,
Wang WB, Song HN, Luo X, Chen XL and Huang DD: Influence of body
composition, muscle strength, and physical performance on the
postoperative complications and survival after radical gastrectomy
for gastric cancer: A comprehensive analysis from a large-scale
prospective study. Clin Nutr. 40:3360–3369. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dolan RD, Almasaudi AS, Dieu LB, Horgan
PG, McSorley ST and McMillan DC: The relationship between computed
tomography-derived body composition, systemic inflammatory
response, and survival in patients undergoing surgery for
colorectal cancer. J Cachexia Sarcopenia Muscle. 10:111–122. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lieber RL and Ward SR: Cellular mechanisms
of tissue fibrosis. 4. Structural and functional consequences of
skeletal muscle fibrosis. Am J Physiol Cell Physiol. 305:C241–C252.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chu MP, Lieffers J, Ghosh S, Belch A, Chua
NS, Fontaine A, Sangha R, Turner RA, Baracos VE and Sawyer MB:
Skeletal muscle density is an independent predictor of diffuse
large B-cell lymphoma outcomes treated with rituximab-based
chemoimmunotherapy. J Cachexia Sarcopenia Muscle. 8:298–304. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Larsson L, Degens H, Li M, Salviati L, Lee
YI, Thompson W, Kirkland JL and Sandri M: Sarcopenia: Aging-related
loss of muscle mass and function. Physiol Rev. 99:427–511. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schaap LA, Pluijm SM, Deeg DJ, Harris TB,
Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky
FA, et al: Higher inflammatory marker levels in older persons:
Associations with 5-year change in muscle mass and muscle strength.
J Gerontol A Biol Sci Med Sci. 64:1183–1189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Landi F, Camprubi-Robles M, Bear DE,
Cederholm T, Malafarina V, Welch AA and Cruz-Jentoft AJ: Muscle
loss: The new malnutrition challenge in clinical practice. Clin
Nutr. 38:2113–2120. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Tang T, Pang L, Sharma SV, Li R,
Nyitray AG and Edwards BJ: Malnutrition and overall survival in
older adults with cancer: A systematic review and meta-analysis. J
Geriatr Oncol. 10:874–883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ruan GT, Zhang Q, Zhang X, Tang M, Song
MM, Zhang XW, Li XR, Zhanf KP, Ge YZ, Yang M, et al: Geriatric
nutrition risk index: Prognostic factor related to inflammation in
elderly patients with cancer cachexia. J Cachexia Sarcopenia
Muscle. 12:1969–1982. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamamoto K, Nagatsuma Y, Fukuda Y, Hirao
M, Nishikawa K, Miyamoto A, Ikeda M, Nakamori S, Sekimoto M,
Fujitani K and Tsujinaka T: Effectiveness of a preoperative
exercise and nutritional support program for elderly sarcopenic
patients with gastric cancer. Gastric Cancer. 20:913–918. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Morishima T, Matsumoto Y, Koeda N, Shimada
H, Maruhama T, Matsuki D, Nakata K, Ito Y, Tabuchi T and Miyashiro
I: Impact of comorbidities on survival in gastric, colorectal, and
lung cancer patients. J Epidemiol. 29:110–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
